These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 31291845)

  • 1. Differences in clinico-pathological characteristics and outcomes between proteinase 3-ANCA positivity and myeloperoxidase-ANCA positivity in lupus nephritis.
    Li C; Wang JJ; Zhou ML; Liang DD; Yang J; Zhu HX; Hu WX; Zhang HT
    Lupus; 2019 Aug; 28(9):1111-1119. PubMed ID: 31291845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ANCA positivity at the time of renal biopsy is associated with chronicity index of lupus nephritis.
    Pyo JY; Jung SM; Song JJ; Park YB; Lee SW
    Rheumatol Int; 2019 May; 39(5):879-884. PubMed ID: 30806732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment and clinicopathological characteristics of lupus nephritis with anti-neutrophil cytoplasmic antibody positivity: a case-control study.
    Li C; Zhou ML; Liang DD; Wang JJ; Yang J; Zeng CH; Liu ZH; Zhang HT
    BMJ Open; 2017 Jul; 7(7):e015668. PubMed ID: 28756384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antineutrophil Cytoplasmic Antibody in Lupus Nephritis: Correlation with Clinicopathological Characteristics and Disease Activity.
    Said D; Rashad NM; Abdelrahmanc NS; Dawaa GA
    Curr Rheumatol Rev; 2021; 17(2):213-221. PubMed ID: 33292154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinction between MPO-ANCA and PR3-ANCA-associated glomerulonephritis in Chinese patients: a retrospective single-center study.
    Hong Y; Shi P; Liu X; Yang L; Li K; Xu F; Liang S; Liu Z; Zhang H; Chen Y; Hu W
    Clin Rheumatol; 2019 Jun; 38(6):1665-1673. PubMed ID: 30737591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significance of anti-neutrophil cytoplasmic antibodies in systemic sclerosis.
    Moxey J; Huq M; Proudman S; Sahhar J; Ngian GS; Walker J; Strickland G; Wilson M; Ross L; Major G; Roddy J; Stevens W; Nikpour M
    Arthritis Res Ther; 2019 Feb; 21(1):57. PubMed ID: 30764870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-neutrophil cytoplasmic antibodies (ANCA) in systemic lupus erythematosus: prevalence, clinical associations and correlation with other autoantibodies.
    Pradhan VD; Badakere SS; Bichile LS; Almeida AF
    J Assoc Physicians India; 2004 Jul; 52():533-7. PubMed ID: 15645975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myeloperoxidase-antineutrophil Cytoplasmic Antibodies (MPO-ANCA) and Proteinase 3-ANCA without Immunofluorescent ANCA Found by Routine Clinical Testing.
    Rao DA; Wei K; Merola JF; O'Brien WR; Takvorian SU; Dellaripa PF; Schur PH
    J Rheumatol; 2015 May; 42(5):847-52. PubMed ID: 25834211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical features and outcomes of patients with antineutrophil cytoplasmic antibody-positive systemic lupus erythematosus.
    Wang Y; Yu X; Xie X; Li H; Yang W; Liang Y; Lu W
    Ren Fail; 2023 Dec; 45(1):2235431. PubMed ID: 37470370
    [No Abstract]   [Full Text] [Related]  

  • 10. A population-based study showing better renal prognosis for proteinase 3 antineutrophil cytoplasmic antibody (ANCA)-associated nephritis versus myeloperoxidase ANCA-associated nephritis.
    Mohammad AJ; Segelmark M
    J Rheumatol; 2014 Jul; 41(7):1366-73. PubMed ID: 24882836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of positive anti-neutrophil cytoplasmic antibodies without evidence of anti-neutrophil cytoplasmic antibodies-associated vasculitis.
    Bornstein G; Ben-Zvi I; Furie N; Grossman C
    Int J Rheum Dis; 2019 May; 22(5):940-945. PubMed ID: 30729688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathologic characteristics and outcomes of lupus nephritis with positive antineutrophil cytoplasmic antibody.
    Wang S; Shang J; Xiao J; Zhao Z
    Ren Fail; 2020 Nov; 42(1):244-254. PubMed ID: 32228220
    [No Abstract]   [Full Text] [Related]  

  • 13. IgG from myeloperoxidase-antineutrophil cytoplasmic antibody-positive patients stimulates greater activation of primed neutrophils than IgG from proteinase 3-antineutrophil cytosplasmic antibody-positive patients.
    Harper L; Radford D; Plant T; Drayson M; Adu D; Savage CO
    Arthritis Rheum; 2001 Apr; 44(4):921-30. PubMed ID: 11315931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myeloperoxidase-Antineutrophil Cytoplasmic Antibody (ANCA)-Positive Granulomatosis With Polyangiitis (Wegener's) Is a Clinically Distinct Subset of ANCA-Associated Vasculitis: A Retrospective Analysis of 315 Patients From a German Vasculitis Referral Center.
    Schirmer JH; Wright MN; Herrmann K; Laudien M; Nölle B; Reinhold-Keller E; Bremer JP; Moosig F; Holle JU
    Arthritis Rheumatol; 2016 Dec; 68(12):2953-2963. PubMed ID: 27333332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolonged infections associated with antineutrophil cytoplasmic antibodies specific to proteinase 3 and myeloperoxidase: diagnostic and therapeutic challenge.
    Bonaci-Nikolic B; Andrejevic S; Pavlovic M; Dimcic Z; Ivanovic B; Nikolic M
    Clin Rheumatol; 2010 Aug; 29(8):893-904. PubMed ID: 20306213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cimetidine-induced tubulointerstitial nephritis with both MPO-ANCA and PR3-ANCA.
    Ueda H; Ishimura E; Yunoki T; Tsuchida T; Matsumoto N; Jono S; Imanishi Y; Inaba M; Nishizawa Y
    Clin Exp Nephrol; 2005 Dec; 9(4):332-334. PubMed ID: 16362162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical characteristics of patients with vasculitis positive for anti-neutrophil cytoplasmic antibody targeting both proteinase 3 and myeloperoxidase: a retrospective study.
    Kim SM; Choi SY; Kim SY; Kim J
    Rheumatol Int; 2019 Nov; 39(11):1919-1926. PubMed ID: 31552433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and spectrum of rheumatic diseases associated with proteinase 3-antineutrophil cytoplasmic antibodies (ANCA) and myeloperoxidase-ANCA.
    Schönermarck U; Lamprecht P; Csernok E; Gross WL
    Rheumatology (Oxford); 2001 Feb; 40(2):178-84. PubMed ID: 11257154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myeloperoxidase-Antineutrophil Cytoplasmic Antibody (ANCA)-Positive and ANCA-Negative Patients With Granulomatosis With Polyangiitis (Wegener's): Distinct Patient Subsets.
    Miloslavsky EM; Lu N; Unizony S; Choi HK; Merkel PA; Seo P; Spiera R; Langford CA; Hoffman GS; Kallenberg CG; St Clair EW; Tchao NK; Fervenza F; Monach PA; Specks U; Stone JH
    Arthritis Rheumatol; 2016 Dec; 68(12):2945-2952. PubMed ID: 27428559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative investigation of respiratory tract involvement in granulomatosis with polyangiitis between PR3-ANCA positive and MPO-ANCA positive cases: a retrospective cohort study.
    Ikeda S; Arita M; Misaki K; Kashiwagi Y; Ito Y; Yamada H; Hotta M; Nishiyama A; Ito A; Noyama M; Koyama T; Notohara K; Ishida T
    BMC Pulm Med; 2015 Jul; 15():78. PubMed ID: 26223225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.